EUVIMEDEUVIMED entdecken
Open Access

Combining sequence data from multiple studies: Impact of analysis strategies on rare variant calling and association results

Zhongsheng Chen iD, Michael Boehnke, Christian Fuchsberger

Genetic Epidemiology · 2020-01 · 44 (1) · 41-51

DOI: 10.1002/gepi.22261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Epidemiology, online erschienen am 14.09.2019. Verfasst von Zhongsheng Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, Michigan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, National Human Genome Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individual sequencing studies often have limited sample sizes and so limited power to detect trait associations with rare variants. A common strategy is to aggregate data from multiple studies. For studying rare variants, jointly calling all samples together is the gold standard strategy but can be difficult to implement due to privacy restrictions and computational burden. Here, we compare joint calling to the alternative of single‐study calling in terms of variant detection sensitivity and genotype accuracy as a function of sequencing coverage and assess their impact on downstream association analysis. To do so, we analyze deep‐coverage (~82×) exome and low‐coverage (~5×) genome sequence data on 2,250 individuals from the Genetics of Type 2 Diabetes study jointly and separately within five geographic cohorts. For rare single nucleotide variants (SNVs): (a) ≥97% of discovered SNVs are found by both calling strategies; (b) nonreference concordance with a set of highly accurate genotypes is ≥99% for both calling strategies; (c) meta‐analysis has similar power to joint analysis in deep‐coverage sequence data but can be less powerful in low‐coverage sequence data. Given similar data processing and quality control steps, we recommend single‐study calling as a viable alternative to joint calling for analyzing SNVs of all minor allele frequency in deep‐coverage data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2ExomeGene FrequencyGenotypeHigh-Throughput Nucleotide SequencingHumansPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Sequencing studiesjoint analysismeta-analysisrare variants

Autor:innen und Institutionen

  • Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, Michigan.
  • Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy.
  • Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.

ORCID-Profile: Zhongsheng Chen

Förderung

  • NHGRI NIH HHS
  • National Human Genome Research Institute

Zitieren

APA

Chen, Z., Boehnke, M., & Fuchsberger, C. (2020). Combining sequence data from multiple studies: Impact of analysis strategies on rare variant calling and association results. Genetic Epidemiology, 44(1), 41-51. https://doi.org/10.1002/gepi.22261

Vancouver

Chen Z, Boehnke M, Fuchsberger C. Combining sequence data from multiple studies: Impact of analysis strategies on rare variant calling and association results. Genetic Epidemiology. 2020;44(1):41-51. doi:10.1002/gepi.22261

BibTeX
@article{Chen2020,
  author = {Chen, Zhongsheng and Boehnke, Michael and Fuchsberger, Christian},
  title = {Combining sequence data from multiple studies: Impact of analysis strategies on rare variant calling and association results},
  journal = {Genetic Epidemiology},
  year = {2020},
  volume = {44},
  number = {1},
  pages = {41--51},
  doi = {10.1002/gepi.22261}
}
Kostenlos starten →